Clarivate PLC (CLVT) reported $621.4 million in revenue for the quarter ended June 2025, representing a year-over-year decline of 4.4%. EPS of $0.18 for the same period compares to $0.20 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $590.76 million, representing a surprise of +5.19%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.18.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Clarivate performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Academia & Government: $318.5 million versus the four-analyst average estimate of $308.52 million. The reported number represents a year-over-year change of -7.6%.
- Revenues- Intellectual Property: $202.5 million versus the four-analyst average estimate of $190.4 million. The reported number represents a year-over-year change of +0.5%.
- Revenues- Life Sciences & Healthcare: $100.4 million compared to the $92.85 million average estimate based on four analysts. The reported number represents a change of -3.7% year over year.
- Revenues- Subscription revenues: $405.7 million versus the two-analyst average estimate of $402.83 million. The reported number represents a year-over-year change of 0%.
- Revenues- Re-occurring revenues: $108.9 million compared to the $109.35 million average estimate based on two analysts. The reported number represents a change of +0.3% year over year.
- Revenues- Transactional and other revenues: $106.8 million versus $74.37 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -21.5% change.
View all Key Company Metrics for Clarivate here>>>
Shares of Clarivate have returned -6.2% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Clarivate PLC (CLVT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
